Piracetam Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 200 mg/ml, 500 mg/ml
Reference Brands: Nootropil (EU/India), Piratropil (India)
Category:
Antipsychotropic Drugs
Piracetam is most commonly used for breath-holding attacks, seizure disorder (epilepsy), dizziness (vertigo), a learning disorder marked by difficulty reading (dyslexia), and a movement disorder often caused by antipsychotic drugs (tardive dyskinesia).
Piracetam Injection is available in Injection
and strengths such as 200 mg/ml, 500 mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Piracetam Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Piracetam Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Piracetam is a nootropic and neuroprotective medication widely used for the management of various neurological and cognitive disorders. It has shown efficacy in conditions such as cognitive impairment, vertigo, cortical myoclonus, dyslexia, and as an adjunct in sickle cell anemia. While studies differ on its effectiveness in treating dementia, Piracetam is recognized in many countries for improving memory, learning, and overall cognitive function.
The drug is primarily marketed and sold in European countries, where it is available in tablet, oral solution, and injectable forms. It works by modulating neurotransmission, enhancing cerebral blood flow, and improving oxygen and glucose utilization in the brain. Although widely used globally, Piracetam is not approved for general medical use in the United States. It is generally well tolerated, with mild side effects such as headache, nausea, or gastrointestinal discomfort reported in some patients. Its safety profile and cognitive-enhancing properties make it a preferred option for managing a range of neurological conditions under medical supervision.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing